Growth During Infancy and Early Childhood and Its Association With Metabolic Risk Biomarkers at 11.5 Years of Age.

Zhang, Xun; Martin, Richard M; Oken, Emily; Aris, Izzuddin M; Yang, Seungmi; Kramer, Michael S

Zhang, Xun; Martin, Richard M; Oken, Emily; Aris, Izzuddin M; Yang, Seungmi; Kramer, Michael S.

Afiliação

Zhang X; Department of Obstetrics and Gynecology, School of Medicine, National University of Singapore, Singapore.
Martin RM; Division of Chronic Disease Research Across the Lifecourse, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Oken E; NIHR Bristol Biomedical Research Centre, Bristol, United Kingdom.
Aris IM; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Yang S; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Kramer MS; Author affiliations: Department of Pediatrics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Am J Epidemiol ; 189(4): 286-293, 2020 04 02.

Article em En | MEDLINE | ID: mdl-31595955

Assuntos

Adiponectina/sangue; Glicemia; Desenvolvimento Infantil; Insulina/sangue; Biomarcadores/sangue; Criança; Pré-Escolar; Humanos; Lactente; Recém-Nascido

Palavras-chave

developmental origins of health and disease; growth; metabolic risk; sensitive periods

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Desenvolvimento Infantil / Adiponectina / Insulina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant / Newborn Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google